MRF Q3 Results: Stock jumps 8% after strong operating performance; Dividend declared

MRF’s board has also approved its second interim dividend of ₹3 per share, and the record date for the same has been fixed as Friday, February 13.

MRF’s board has also approved its second interim dividend of ₹3 per share, and the record date for the same has been fixed as Friday, February 13.

Greaves Cotton reported a strong Q3 performance with profit and EBITDA rising sharply year-on-year, supported by healthy revenue growth and margin expansion; shares traded higher after the results.

Zydus Lifesciences received USFDA Orphan Drug Designation for Desidustat to treat Sickle Cell Disease, with incentives and study data pending publication.

All GMP certificates issued by NCPHP revoked; corrective actions underway, EU exports form 0.32% of Panacea Biotec Limited’s revenue

Bharti Airtel posted steady Q3 growth with revenues and EBITDA rising sequentially, driven by higher ARPU, strong Homes additions and Africa performance, even as net profit eased marginally.

Shares of VRL Logistics Ltd ended at ₹278.30, down by ₹4.50, or 1.59%, on the BSE.

Yields on the 10-year bonds increased sharply soon after the end of the Governor’s statement. Here’s why.

The announcement on January 1 had triggered a sharp fall in shares of ITC, prompting multiple downgrades by analysts, who feared risks to the company’s earnings estimates. The stock fell to the lowest level in three years, with the number…

Alembic Pharmaceuticals received USFDA approval for Carbidopa, Levodopa and Entacapone tablets, which is indicated for the treatment of Parkinson’s disease. Q3 revenue rose 10.8% but net profit fell 4.1%.

Bhavin Shah, Founder and CEO of Sameeksha Capital said that his firm is re-evaluating its IT holdings with a bias towards selling amid growing market uncertainty.